| Literature DB >> 29975394 |
Abstract
Acute and chronic insomnia are common and difficult clinical problems that contribute to and are consequences of other mental and physical health problems. It is tempting to treat insomnia with medications for rapid relief; however, these medications have significant side effects that add health burden and may cause tolerance and dependency. First-line treatment for insomnia is cognitive-behavioral therapy for insomnia (CBT-I); however, this is less frequently prescribed than benzodiazepine and non-benzodiazepine sedative hypnotic agents. Prudent primary care and mental health clinicians should screen for insomnia using valid and reliable tools when clients report sleep difficulties. When screening is positive, further assessment with a sleep diary is warranted. The primary treatment for insomnia is CBT-I, and pharmacological treatment may provide temporary support for no more than 2 to 4 weeks. Non-benzodiazepine hypnotic agents, histamine blocking medications, dual orexin receptor antagonists, and over-the-counter herbal supplements may serve as adjuncts. [Journal of Psychosocial Nursing and Mental Health Services, 56(7), 9-14.]. Copyright 2018, SLACK Incorporated.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29975394 DOI: 10.3928/02793695-20180619-03
Source DB: PubMed Journal: J Psychosoc Nurs Ment Health Serv ISSN: 0279-3695 Impact factor: 1.098